Ignite Creation Date:
2024-05-06 @ 7:37 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06079554
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2023-10-06
Brief Title:
Microbiota and Metabolomics of Intestinal Type of Gastric Cancer
Sponsor:
Jilin University
Organization:
Jilin University
Study Overview
Official Title:
Microbiota and Metabolomics of Intestinal Type of Gastric Cancer in the Context of Atrophic Gastritis
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Compare with the gastric cavity without cancerous transformation in atrophic gastritis analyze the microbiota and metabolomics changes in intestinal type of gastric cancer under the background of atrophic gastritis and explore the relevant mechanisms
Detailed Description:
This study adopts a prospective cohort study The expected recruitment time for all participants is 6 months and all cases are cases who would receive magnifying endoscopy examination The extent of atrophy and the presence of early gastric cancer are determined under magnifying endoscopy Cases are chose into the gastric cancer group and atrophic gastritis group in a 11 ratio There are 16 cases of intestinal type of gastric cancer under the background of atrophic gastritis and 16 cases of atrophic gastritis without gastric cancer matched according to gender age and degree of gastric atrophy totaling 32 cases Analyze the characteristics of early gastric cancer under endoscopy investigate the changes in microbiota and metabolomics of intestinal type of gastric cancer under the background of atrophic gastritis and explore the relevant mechanisms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None